Offer - Urjas Oil for just ₹ 1 X
Onglyza, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes.
The correct dosage of Onglyza depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Onglyza include Nausea or vomiting, Dizziness, Low Blood Sugar (Hypoglycemia). Some other side effects of Onglyza have been listed ahead. Such side effects of Onglyza normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Onglyza's effect during pregnancy is Unknown and Moderate while nursing. In addition, Onglyza's effects on the liver, heart and kidney are discussed below in the Onglyza related warnings section.
Onglyza can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Onglyza in conditions like Pancreatitis. Some other conditions that can be affected by Onglyza are listed in the contraindications section below.
Additionally, Onglyza may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Onglyza is safe while driving, and is is addictive in nature.
Onglyza is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Onglyza safe for pregnant women?
No research has been done to ascertain the safety of Onglyza in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Onglyza safe during breastfeeding?
Onglyza can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Onglyza on the Kidneys?
Onglyza may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Onglyza on the Liver?
The liver can be affected by Onglyza. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Onglyza only after medical advice.
What is the effect of Onglyza on the Heart?
There may be an adverse effect on the heart after taking Onglyza. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Onglyza should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Onglyza unless your doctor advises you to do so -
Is this Onglyza habit forming or addictive?
Forming a habit of Onglyza has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Onglyza does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Onglyza is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Onglyza is unable to treat or cure mental disorders.
Interaction between Food and Onglyza
Taking Onglyza with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Onglyza
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Onglyza.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Onglyza (saxagliptin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1125-1126